Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The changing paradigm of prognostic factors in acute myeloid leukaemia.

Best practice & research. Clinical haematology - 1 Dec 2012

Grimwade David

Abstract excerpt

Acute myeloid leukaemia (AML) is a highly heterogeneous disease, with biologically and prognostically different subtypes distinguished by cytogenetic and molecular genetic analysis, as recognised in the latest (2008) WHO classification system. However, since the publication of this schema, applic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cell Transformation, Neoplastic
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Neoplasm, Residual

Share to Prognosis

Share to Retinoids in leukemia and cellular processes

Source

Identifiers

PMID: 23200538
DOI: 10.1016/j.beha.2012.10.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23200538-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The changing paradigm of prognostic factors in acute myeloid leukaemia.PMID 23200538Read ↗

Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights.Semantic proximity Read ↗

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapiesSemantic proximity Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Acute myeloid leukaemia: How to combine multiple tools.Semantic proximity Read ↗

Clinical implications of molecular markers in acute myeloid leukemia.Semantic proximity Read ↗

Advances in therapeutic options for newly diagnosed, high-risk AML patientsSemantic proximity Read ↗

Unified classification and risk-stratification in Acute Myeloid LeukemiaSemantic proximity Read ↗

Classification and risk assessment in AML: integrating cytogenetics and molecular profilingSemantic proximity Read ↗

The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies.Semantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Molecular characterization of acute myeloid leukemia and its impact on treatment.Semantic proximity Read ↗

Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.